Systemic Erythropoietin Injection in Patients Having Optic Atrophy
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Visual acuity
研究概览
简要总结
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.
详细描述
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy. The intervention is systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days).
Follow up after one month and three months by recording visual acuity and electro physiological studies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Post papilledemic optic atrophy patients
排除标准
- •Refuse to give an informed consent
研究组 & 干预措施
Systemic erythropoietin injections
The study included 10 patients diagnosed as post papilledemic optic atrophy
干预措施: Systemic erythropoietin injection (Drug)
结局指标
主要结局
Visual acuity
时间窗: 3 months
VIsual acuity assessed at the follow up
Pattern visual evoked Potential .
时间窗: 3 months
Pattern visual evoked Potential .in both eyes to use data of the normal fellow eye as patients' internal control
Pattern electroretinogram
时间窗: 3 months
Pattern electroretinogram in both eyes to use data of the normal fellow eye as patients' internal control
次要结局
未报告次要终点
研究者
Mohamed Fahmy Doheim
Prinicipal investigator
Alexandria University